BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity

  July 16, 2025

   · 

  6 min read
• Press Releases

  Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

  July 16, 2025

   · 

  8 min read
• Press Releases

  BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

  July 16, 2025

   · 

  3 min read
• Press Releases

  Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

  July 16, 2025

   · 

  1 min read
• Press Releases

  Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide

  July 16, 2025

   · 

  7 min read
• Press Releases

  GT Medical Technologies Completes Final Close of Company’s Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors

  July 16, 2025

   · 

  3 min read
• Press Releases

  Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

  July 16, 2025

   · 

  5 min read
• Press Releases

  OncoC4 to Present at the 2025 Orphan Drug Summit on Strategies to Eliminate Anti-Drug Antibodies in Orphan Therapies

  July 16, 2025

   · 

  2 min read
• Press Releases

  Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA

  July 16, 2025

   · 

  4 min read
• Press Releases

  OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

  July 16, 2025

   · 

  3 min read